Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jonathan Filskov"'
Publikováno v:
Scientific Reports
Filskov, J, Andersen, P, Agger, E M & Bukh, J 2019, ' HCV p7 as a novel vaccine-target inducing multifunctional CD4 + and CD8 + T-cells targeting liver cells expressing the viral antigen ', Scientific Reports, vol. 9, no. 1, 14085 . https://doi.org/10.1038/s41598-019-50365-z
Scientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
Filskov, J, Andersen, P, Agger, E M & Bukh, J 2019, ' HCV p7 as a novel vaccine-target inducing multifunctional CD4 + and CD8 + T-cells targeting liver cells expressing the viral antigen ', Scientific Reports, vol. 9, no. 1, 14085 . https://doi.org/10.1038/s41598-019-50365-z
Scientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
Despite recent treatment advances for chronic hepatitis C virus (HCV) infection, a vaccine is urgently needed for global control of this important liver pathogen. The lack of robust immunocompetent HCV infection models makes it challenging to identif
Autor:
Jean-Michel Pawlotsky, Sanne B. Jensen, Henrik Krarup, Christina Sølund, Daryl Humes, Stéphanie B. N. Serre, Christoph Sarrazin, Santseharay Ramirez, Jonathan Filskov, Judith M. Gottwein, Long V. Pham, Jens Bukh, Anne Finne Pihl, Lubna Ghanem, Julia Dietz, Slim Fourati, Ulrik Fahnøe, Nina Weis, Kristian Schønning, Qi Tang, Martin Schou Pedersen
Publikováno v:
Hepatology (Baltimore, Md.)
Jensen, S B, Fahnøe, U, Pham, L V, Serre, S, Tang, Q, Ghanem, L, Pedersen, M S, Ramirez, S, Humes, D, Pihl, A F, Filskov, J, Sølund, C S, Dietz, J, Fourati, S, Pawlotsky, J-M, Sarrazin, C, Weis, N, Schønning, K, Krarup, H, Bukh, J & Gottwein, J M 2019, ' Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants ', Hepatology, vol. 70, no. 3, pp. 771-787 . https://doi.org/10.1002/hep.30647
Jensen, S B, Fahnøe, U, Pham, L V, Serre, S B N, Tang, Q, Ghanem, L, Pedersen, M S, Ramirez, S, Humes, D, Pihl, A F, Filskov, J, Sølund, C S, Dietz, J, Fourati, S, Pawlotsky, J M, Sarrazin, C, Weis, N, Schønning, K, Krarup, H, Bukh, J & Gottwein, J M 2019, ' Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants ', Hepatology, vol. 70, no. 3, pp. 771-787 . https://doi.org/10.1002/hep.30647
Jensen, S B, Fahnøe, U, Pham, L V, Serre, S, Tang, Q, Ghanem, L, Pedersen, M S, Ramirez, S, Humes, D, Pihl, A F, Filskov, J, Sølund, C S, Dietz, J, Fourati, S, Pawlotsky, J-M, Sarrazin, C, Weis, N, Schønning, K, Krarup, H, Bukh, J & Gottwein, J M 2019, ' Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants ', Hepatology, vol. 70, no. 3, pp. 771-787 . https://doi.org/10.1002/hep.30647
Jensen, S B, Fahnøe, U, Pham, L V, Serre, S B N, Tang, Q, Ghanem, L, Pedersen, M S, Ramirez, S, Humes, D, Pihl, A F, Filskov, J, Sølund, C S, Dietz, J, Fourati, S, Pawlotsky, J M, Sarrazin, C, Weis, N, Schønning, K, Krarup, H, Bukh, J & Gottwein, J M 2019, ' Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants ', Hepatology, vol. 70, no. 3, pp. 771-787 . https://doi.org/10.1002/hep.30647
Protease inhibitors (PIs) are important components of treatment regimens for patients with chronic hepatitis C virus (HCV) infection. However, emergence and persistence of antiviral resistance could reduce their efficacy. Thus, defining resistance de
Autor:
Allan Randrup Thomsen, Jonathan Filskov, Paul R. Hansen, Jens Bukh, Else Marie Agger, Marianne Mikkelsen, Peter Andersen, Jan Pravsgaard Christensen
Publikováno v:
Journal of Virology. 91
Despite the introduction of effective drugs to treat patients with chronic hepatitis C virus (HCV) infection, a vaccine would be the only means to substantially reduce the worldwide disease burden. An incomplete understanding of how HCV interacts wit
Autor:
Jonathan, Filskov, Marianne, Mikkelsen, Paul R, Hansen, Jan P, Christensen, Allan R, Thomsen, Peter, Andersen, Jens, Bukh, Else Marie, Agger
Publikováno v:
Journal of virology. 91(14)
Despite the introduction of effective drugs to treat patients with chronic hepatitis C virus (HCV) infection, a vaccine would be the only means to substantially reduce the worldwide disease burden. An incomplete understanding of how HCV interacts wit
Autor:
Karen Smith Korsholm, Thomas Lindenstrøm, Jonathan Filskov, Kasper Karlsen, Signe Tandrup Schmidt, Marianne Mikkelsen, Peter Andersen, Jon Hansen, Dennis Christensen
Publikováno v:
Vaccine. 32:3927-3935
Vaccines inducing cytotoxic T-cell responses are required to achieve protection against cancers and intracellular infections such as HIV and Hepatitis C virus. Induction of CD8+ T cell responses in animal models can be achieved by the use of viral ve
Autor:
Joseph P. Cassidy, Jonathan Filskov, Jes Dietrich, Erik Michael Rasmussen, Peter Andersen, Thomas Lindenstrøm, Ida Rosenkrands, Sugata Roy
When infected with Mycobacterium tuberculosis, most individuals will remain clinically healthy but latently infected. Latent infection has been proposed to partially involve M. tuberculosis in a nonreplicating stage, which therefore represents an M.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::898af1bf1efeb9b3703d819c73b0087d
https://europepmc.org/articles/PMC4730563/
https://europepmc.org/articles/PMC4730563/
Autor:
Thomas Lindenstrøm, Ida Rosenkrands, Joseph P. Cassidy, Jonathan Filskov, Jes Dietrich, Sugata Roy, Erik Michael Rasmussen, Peter Andersen
When infected with Mycobacterium tuberculosis , most individuals will remain clinically healthy but latently infected. Latent infection has been proposed to partially involve M. tuberculosis in a nonreplicating stage, which therefore represents an M.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3623fd562e0463d4b45836ad844fad2
https://europepmc.org/articles/PMC4645392/
https://europepmc.org/articles/PMC4645392/